ArticleBMJ open2025

Cost-utility analysis of MR imaging-guided transurethral ultrasound ablation for the treatment of low- to intermediate-risk localised prostate cancer.

Paul Muhler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.